No Data
No Data
Insider Selling: CFO Kevin Green Sells 82,657 Shares of Cerus Corp (CERS)
Institutional Investors Have a Lot Riding on Cerus Corporation (NASDAQ:CERS) With 65% Ownership
ZoomInfo Reports Weak Results, Joins Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
MercadoLibre Posts Upbeat Results, Joins Integral Ad Science, Willdan Group, Fresh Del Monte Produce And Other Big Stocks Moving Higher On Friday
Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating
Craig-Hallum analyst William Bonello maintains $Cerus(CERS.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 61.5% and a total average return of 35.4% over the
Analysts Offer Insights on Healthcare Companies: Takeda Pharmaceutical Co (OtherTKPHF), Cerus (CERS) and Ultragenyx Pharmaceutical (RARE)